Genetics, Neurology, Behavior, and Diet in Parkinson's Disease
The Neuroscience of Parkinson's Disease, Volume 2
Herausgeber: R Martin, Colin; Preedy, Victor R
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
Genetics, Neurology, Behavior, and Diet in Parkinson's Disease
The Neuroscience of Parkinson's Disease, Volume 2
Herausgeber: R Martin, Colin; Preedy, Victor R
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Genetics, Neurology, Behavior, and Diet in Parkinson's Disease: The Neuroscience of Parkinson's Disease, Volume 2 provides a single source of material covering different scientific domains of neuropathology underlying this condition. The book covers a wide range of subjects and unravels the complex relationships between genetics, molecular biology, pharmaceutical chemistry, neurobiology, imaging, assessments, and treatment regimens. It fills a much-needed gap as a "one-stop" synopsis of everything to do with the neurology and neuroscience related to Parkinson's disease-from chemicals and cells…mehr
Andere Kunden interessierten sich auch für
Genetics, Neurology, Behavior, and Diet in Parkinson's Disease: The Neuroscience of Parkinson's Disease, Volume 2 provides a single source of material covering different scientific domains of neuropathology underlying this condition. The book covers a wide range of subjects and unravels the complex relationships between genetics, molecular biology, pharmaceutical chemistry, neurobiology, imaging, assessments, and treatment regimens. It fills a much-needed gap as a "one-stop" synopsis of everything to do with the neurology and neuroscience related to Parkinson's disease-from chemicals and cells to individuals. It is an invaluable resource for neuroscientists, neurologists, and anyone in the field.
Produktdetails
- Produktdetails
- Verlag: Elsevier Health Sciences
- Seitenzahl: 762
- Erscheinungstermin: 18. September 2020
- Englisch
- Gewicht: 1930g
- ISBN-13: 9780128159507
- ISBN-10: 0128159502
- Artikelnr.: 58812154
- Verlag: Elsevier Health Sciences
- Seitenzahl: 762
- Erscheinungstermin: 18. September 2020
- Englisch
- Gewicht: 1930g
- ISBN-13: 9780128159507
- ISBN-10: 0128159502
- Artikelnr.: 58812154
Part I: Genetics, molecular and cellular biology
2. Alpha-synuclein gene and Parkinson's diseaseAthina-Maria Simitsi,
Chistos Koros and Leonidas Stefanis
3. The DJ-1 gene and protein: links with Parkinson's diseaseVanessa J.
Musco, Sarah J. Annesley and Paul R. Fisher
4. Regulation of tyrosine hydroxylase: relevance to Parkinson's
diseaseGelareh Alam and Jason R. Richardson
5. Linking glucocerebrosidase gene (GBA) variants and Parkinson's
diseasectoria Berge-Seidl and Mathias Toft
6. Astrocytes and microglia in Parkinson's disease and animal
modelsKatarzyna Kuter
7. The role of autophagy in Parkinson's disease etiopathogenesisEmanuel
Candeias, Jãao Duarte Magalhães, Daniel Santos, Helena Costa, Diana F.
Silva, Ana Raquel Esteves and Sandra Morais Cardoso
8. The mitochondrial network in Parkinson's diseaseAndreas Aufschnaiter,
Verena Kohler and Sabrina Büttner
9. Signal transduction in Parkinson's disease: modulation of
neurotransmission, symptomatology, and therapyMattia Volta
10. Oxidative stress signaling and regulated cell death in Parkinson's
diseaseCarlos Velez-Pardo and Marlene Jimenez-Del-Rio
11. Subcellular-specific alpha-synuclein in Parkinson's diseaseBenjamin
Rosen, Ketan S. Patil, Guido W. Alves and Simon G. Møller
12. Melanocortin 1 receptor: Parkinson's disease, melanoma risk, and
neuroprotectionGemma Tell-Marti, Joan Anton Puig-Butillé and Susana Puig
13. Energy regulation and Parkinson's diseaseLiting Hang and Kah-Leong Lim
14. Linking rotigotine, Parkinson's disease, and brain-derived neurotrophic
factorKazuhiro Sohya, Kazunori O'Hashi and Hiroshi Kunugi
Part II: Neurology, physiology and imaging
15. The different syndromes in Parkinson's disease: an overviewNikolaos
Giagkou and Maria Stamelou
16. Neuromolecular imaging in Parkinson's diseasePatricia A. Broderick and
Leslie Wenning
17. Interlinking brain mapping and Parkinson's disease: MRI analysis,
nigrosome 1 and nigrosome 4Eung Yeop Kim, Young Hee Sung and Jongho Lee
18. Interconnecting Parkinson's disease: the use of computed tomography and
microelectrode recording in DBS surgeryRyan B. Kochanski and Sepehr Sani
19. Linking diffusion tensor imaging, microstructures and Parkinson's
diseaseYu Zhang, Norbert Schuff, I-Wei Wu and Duygu Tosun
20. Detecting parkinsonian degeneration in lateroventral tier of substantia
nigra pars compacta with MRIJason Langley, Daniel E. Huddleston and
Xiaoping P. Hu
21. Vagal motoneurons in Parkinson's diseaseRuth E. Musgrove, Wei-Hua Chiu
and Joshua A. Goldberg
22. Circadian clock disruption and neuroinflammation in Parkinson's
disease: a new perspective Elisabetta Lauretti and Domenico Praticò
23. Motor cortex stimulation in Parkinson's diseaseAngelo Lavano, Giusy
Guzzi, Attilio Della Torre and Domenico La Torre
24. Action programming disorders associated with Parkinson's diseaseKenneth
M. Heilman
25. The striatal medium spiny neurons: what they are and how they link with
Parkinson's diseaseFu-Ming Zhou
26. Disruptions of frontostriatal language functions in Parkinson's
diseaseAdolfo M. García, Yamile Bocanegra, Agustina Birba, Juan Rafael
Orozco-Arroyave, Lucas Sedeño and Agustín Ibañez
27. Alpha-synuclein and neuroinflammation in Parkinson's diseaseTatiana
Varanita and Luigi Bubacco
28. Tau and its interactions with other proteins in neurodegenerative
diseasesKatelyn H. Mroczek, Sarah J. Annesley and Paul R. Fisher
29. Interaction between brain angiotensin and dopaminergic systems and
Parkinson's diseaseJose Luis Labandeira-Garcia, Pablo Garrido-Gil, Maria A.
Pedrosa, Carmen M. Labandeira and Ana I. Rodriguez-Perez
30. Restoring dopamine levels in Parkinson's disease: neuronal pathways,
agonists and antiinflammatory agentsÁgatha Oliveira-Giacomelli, C.M.
Albino, Hellio Danny Nóbrega de Souza and Henning Ulrich
Part III: Behaviour and psychopathology
31. Motivation and motivational aspects of Parkinson's diseaseAbdeslam
Chagraoui, Emilie Puginier and Philippe De Deurwaerdère
32. Linking anxiety, cognitive and sensory deficits to gait and balance
deficits in Parkinson's diseaseQuincy J. Almeida
33. Motor programs interlinking gait and bradykinesia in Parkinson's
diseaseTateo Warabi, Kiyoharu Inoue and Nobuo Yanagisawa
34. Olfactory disturbances in Parkinson's diseaseLais S. Rodrigues, Juliane
Fagotti, Adriano D.S. Targa, Ana Carolina D. Noseda, Jessica L. Ilkiw,
Flavia W.C. Dorieux and Marcelo M.S. Lima
35. Interlinking dementia in Parkinson's disease: nutritional correlates of
body compositionArthur Oscar Schelp, Jéssica Emy Komuro, José Eduardo
Corrente and Silvia Justina Papini
36. The role of the gastrointestinal system and gut microbiota in
Parkinson's diseaseJade Kenna and Ryan S. Anderton
37. Swallowing impairment in Parkinson's diseaseMaira Rozenfeld Olchik,
Marina Padovani and Annelise Ayres
38. The Mini Nutritional Assessment (MNA) and applications to Parkinson's
diseaseSvetlana Tomic
39. The efficacy of Bacopa monnieri extract in modulating Parkinson's
diseaseDr. Ravikumar Hosamani
Part V: Models, modelling and resources
40. 6-hydroxydopamine-induced model of Parkinson's diseaseKatarzyna
Kaczynska and Kryspin Andrzejewski
41. Knockdown transgenic Drosophila and Parkinson's diseaseMarlene
Jimenez-Del-Rio and Carlos Velez-Pardo
42. Neuroprotection in animal models of Parkinson's disease: exploring
exercise, sound, and lightJohn Mitrofanis
43. Modeling with the A53T a-synuclein model of Parkinson's diseaseThomas
Musacchio, James B. Koprich and Chi Wang Ip
44. Linking the leucine-rich repeat kinase 2 gene, animal models, and
Parkinson's diseaseYulan Xiong and Jianzhong Yu
45. Neuroscience of Parkinson's disease: recommended reading and
resourcesRajkumar Rajendram, Vinood B. Patel and Victor R. Preedy
2. Alpha-synuclein gene and Parkinson's diseaseAthina-Maria Simitsi,
Chistos Koros and Leonidas Stefanis
3. The DJ-1 gene and protein: links with Parkinson's diseaseVanessa J.
Musco, Sarah J. Annesley and Paul R. Fisher
4. Regulation of tyrosine hydroxylase: relevance to Parkinson's
diseaseGelareh Alam and Jason R. Richardson
5. Linking glucocerebrosidase gene (GBA) variants and Parkinson's
diseasectoria Berge-Seidl and Mathias Toft
6. Astrocytes and microglia in Parkinson's disease and animal
modelsKatarzyna Kuter
7. The role of autophagy in Parkinson's disease etiopathogenesisEmanuel
Candeias, Jãao Duarte Magalhães, Daniel Santos, Helena Costa, Diana F.
Silva, Ana Raquel Esteves and Sandra Morais Cardoso
8. The mitochondrial network in Parkinson's diseaseAndreas Aufschnaiter,
Verena Kohler and Sabrina Büttner
9. Signal transduction in Parkinson's disease: modulation of
neurotransmission, symptomatology, and therapyMattia Volta
10. Oxidative stress signaling and regulated cell death in Parkinson's
diseaseCarlos Velez-Pardo and Marlene Jimenez-Del-Rio
11. Subcellular-specific alpha-synuclein in Parkinson's diseaseBenjamin
Rosen, Ketan S. Patil, Guido W. Alves and Simon G. Møller
12. Melanocortin 1 receptor: Parkinson's disease, melanoma risk, and
neuroprotectionGemma Tell-Marti, Joan Anton Puig-Butillé and Susana Puig
13. Energy regulation and Parkinson's diseaseLiting Hang and Kah-Leong Lim
14. Linking rotigotine, Parkinson's disease, and brain-derived neurotrophic
factorKazuhiro Sohya, Kazunori O'Hashi and Hiroshi Kunugi
Part II: Neurology, physiology and imaging
15. The different syndromes in Parkinson's disease: an overviewNikolaos
Giagkou and Maria Stamelou
16. Neuromolecular imaging in Parkinson's diseasePatricia A. Broderick and
Leslie Wenning
17. Interlinking brain mapping and Parkinson's disease: MRI analysis,
nigrosome 1 and nigrosome 4Eung Yeop Kim, Young Hee Sung and Jongho Lee
18. Interconnecting Parkinson's disease: the use of computed tomography and
microelectrode recording in DBS surgeryRyan B. Kochanski and Sepehr Sani
19. Linking diffusion tensor imaging, microstructures and Parkinson's
diseaseYu Zhang, Norbert Schuff, I-Wei Wu and Duygu Tosun
20. Detecting parkinsonian degeneration in lateroventral tier of substantia
nigra pars compacta with MRIJason Langley, Daniel E. Huddleston and
Xiaoping P. Hu
21. Vagal motoneurons in Parkinson's diseaseRuth E. Musgrove, Wei-Hua Chiu
and Joshua A. Goldberg
22. Circadian clock disruption and neuroinflammation in Parkinson's
disease: a new perspective Elisabetta Lauretti and Domenico Praticò
23. Motor cortex stimulation in Parkinson's diseaseAngelo Lavano, Giusy
Guzzi, Attilio Della Torre and Domenico La Torre
24. Action programming disorders associated with Parkinson's diseaseKenneth
M. Heilman
25. The striatal medium spiny neurons: what they are and how they link with
Parkinson's diseaseFu-Ming Zhou
26. Disruptions of frontostriatal language functions in Parkinson's
diseaseAdolfo M. García, Yamile Bocanegra, Agustina Birba, Juan Rafael
Orozco-Arroyave, Lucas Sedeño and Agustín Ibañez
27. Alpha-synuclein and neuroinflammation in Parkinson's diseaseTatiana
Varanita and Luigi Bubacco
28. Tau and its interactions with other proteins in neurodegenerative
diseasesKatelyn H. Mroczek, Sarah J. Annesley and Paul R. Fisher
29. Interaction between brain angiotensin and dopaminergic systems and
Parkinson's diseaseJose Luis Labandeira-Garcia, Pablo Garrido-Gil, Maria A.
Pedrosa, Carmen M. Labandeira and Ana I. Rodriguez-Perez
30. Restoring dopamine levels in Parkinson's disease: neuronal pathways,
agonists and antiinflammatory agentsÁgatha Oliveira-Giacomelli, C.M.
Albino, Hellio Danny Nóbrega de Souza and Henning Ulrich
Part III: Behaviour and psychopathology
31. Motivation and motivational aspects of Parkinson's diseaseAbdeslam
Chagraoui, Emilie Puginier and Philippe De Deurwaerdère
32. Linking anxiety, cognitive and sensory deficits to gait and balance
deficits in Parkinson's diseaseQuincy J. Almeida
33. Motor programs interlinking gait and bradykinesia in Parkinson's
diseaseTateo Warabi, Kiyoharu Inoue and Nobuo Yanagisawa
34. Olfactory disturbances in Parkinson's diseaseLais S. Rodrigues, Juliane
Fagotti, Adriano D.S. Targa, Ana Carolina D. Noseda, Jessica L. Ilkiw,
Flavia W.C. Dorieux and Marcelo M.S. Lima
35. Interlinking dementia in Parkinson's disease: nutritional correlates of
body compositionArthur Oscar Schelp, Jéssica Emy Komuro, José Eduardo
Corrente and Silvia Justina Papini
36. The role of the gastrointestinal system and gut microbiota in
Parkinson's diseaseJade Kenna and Ryan S. Anderton
37. Swallowing impairment in Parkinson's diseaseMaira Rozenfeld Olchik,
Marina Padovani and Annelise Ayres
38. The Mini Nutritional Assessment (MNA) and applications to Parkinson's
diseaseSvetlana Tomic
39. The efficacy of Bacopa monnieri extract in modulating Parkinson's
diseaseDr. Ravikumar Hosamani
Part V: Models, modelling and resources
40. 6-hydroxydopamine-induced model of Parkinson's diseaseKatarzyna
Kaczynska and Kryspin Andrzejewski
41. Knockdown transgenic Drosophila and Parkinson's diseaseMarlene
Jimenez-Del-Rio and Carlos Velez-Pardo
42. Neuroprotection in animal models of Parkinson's disease: exploring
exercise, sound, and lightJohn Mitrofanis
43. Modeling with the A53T a-synuclein model of Parkinson's diseaseThomas
Musacchio, James B. Koprich and Chi Wang Ip
44. Linking the leucine-rich repeat kinase 2 gene, animal models, and
Parkinson's diseaseYulan Xiong and Jianzhong Yu
45. Neuroscience of Parkinson's disease: recommended reading and
resourcesRajkumar Rajendram, Vinood B. Patel and Victor R. Preedy
Part I: Genetics, molecular and cellular biology
2. Alpha-synuclein gene and Parkinson's diseaseAthina-Maria Simitsi,
Chistos Koros and Leonidas Stefanis
3. The DJ-1 gene and protein: links with Parkinson's diseaseVanessa J.
Musco, Sarah J. Annesley and Paul R. Fisher
4. Regulation of tyrosine hydroxylase: relevance to Parkinson's
diseaseGelareh Alam and Jason R. Richardson
5. Linking glucocerebrosidase gene (GBA) variants and Parkinson's
diseasectoria Berge-Seidl and Mathias Toft
6. Astrocytes and microglia in Parkinson's disease and animal
modelsKatarzyna Kuter
7. The role of autophagy in Parkinson's disease etiopathogenesisEmanuel
Candeias, Jãao Duarte Magalhães, Daniel Santos, Helena Costa, Diana F.
Silva, Ana Raquel Esteves and Sandra Morais Cardoso
8. The mitochondrial network in Parkinson's diseaseAndreas Aufschnaiter,
Verena Kohler and Sabrina Büttner
9. Signal transduction in Parkinson's disease: modulation of
neurotransmission, symptomatology, and therapyMattia Volta
10. Oxidative stress signaling and regulated cell death in Parkinson's
diseaseCarlos Velez-Pardo and Marlene Jimenez-Del-Rio
11. Subcellular-specific alpha-synuclein in Parkinson's diseaseBenjamin
Rosen, Ketan S. Patil, Guido W. Alves and Simon G. Møller
12. Melanocortin 1 receptor: Parkinson's disease, melanoma risk, and
neuroprotectionGemma Tell-Marti, Joan Anton Puig-Butillé and Susana Puig
13. Energy regulation and Parkinson's diseaseLiting Hang and Kah-Leong Lim
14. Linking rotigotine, Parkinson's disease, and brain-derived neurotrophic
factorKazuhiro Sohya, Kazunori O'Hashi and Hiroshi Kunugi
Part II: Neurology, physiology and imaging
15. The different syndromes in Parkinson's disease: an overviewNikolaos
Giagkou and Maria Stamelou
16. Neuromolecular imaging in Parkinson's diseasePatricia A. Broderick and
Leslie Wenning
17. Interlinking brain mapping and Parkinson's disease: MRI analysis,
nigrosome 1 and nigrosome 4Eung Yeop Kim, Young Hee Sung and Jongho Lee
18. Interconnecting Parkinson's disease: the use of computed tomography and
microelectrode recording in DBS surgeryRyan B. Kochanski and Sepehr Sani
19. Linking diffusion tensor imaging, microstructures and Parkinson's
diseaseYu Zhang, Norbert Schuff, I-Wei Wu and Duygu Tosun
20. Detecting parkinsonian degeneration in lateroventral tier of substantia
nigra pars compacta with MRIJason Langley, Daniel E. Huddleston and
Xiaoping P. Hu
21. Vagal motoneurons in Parkinson's diseaseRuth E. Musgrove, Wei-Hua Chiu
and Joshua A. Goldberg
22. Circadian clock disruption and neuroinflammation in Parkinson's
disease: a new perspective Elisabetta Lauretti and Domenico Praticò
23. Motor cortex stimulation in Parkinson's diseaseAngelo Lavano, Giusy
Guzzi, Attilio Della Torre and Domenico La Torre
24. Action programming disorders associated with Parkinson's diseaseKenneth
M. Heilman
25. The striatal medium spiny neurons: what they are and how they link with
Parkinson's diseaseFu-Ming Zhou
26. Disruptions of frontostriatal language functions in Parkinson's
diseaseAdolfo M. García, Yamile Bocanegra, Agustina Birba, Juan Rafael
Orozco-Arroyave, Lucas Sedeño and Agustín Ibañez
27. Alpha-synuclein and neuroinflammation in Parkinson's diseaseTatiana
Varanita and Luigi Bubacco
28. Tau and its interactions with other proteins in neurodegenerative
diseasesKatelyn H. Mroczek, Sarah J. Annesley and Paul R. Fisher
29. Interaction between brain angiotensin and dopaminergic systems and
Parkinson's diseaseJose Luis Labandeira-Garcia, Pablo Garrido-Gil, Maria A.
Pedrosa, Carmen M. Labandeira and Ana I. Rodriguez-Perez
30. Restoring dopamine levels in Parkinson's disease: neuronal pathways,
agonists and antiinflammatory agentsÁgatha Oliveira-Giacomelli, C.M.
Albino, Hellio Danny Nóbrega de Souza and Henning Ulrich
Part III: Behaviour and psychopathology
31. Motivation and motivational aspects of Parkinson's diseaseAbdeslam
Chagraoui, Emilie Puginier and Philippe De Deurwaerdère
32. Linking anxiety, cognitive and sensory deficits to gait and balance
deficits in Parkinson's diseaseQuincy J. Almeida
33. Motor programs interlinking gait and bradykinesia in Parkinson's
diseaseTateo Warabi, Kiyoharu Inoue and Nobuo Yanagisawa
34. Olfactory disturbances in Parkinson's diseaseLais S. Rodrigues, Juliane
Fagotti, Adriano D.S. Targa, Ana Carolina D. Noseda, Jessica L. Ilkiw,
Flavia W.C. Dorieux and Marcelo M.S. Lima
35. Interlinking dementia in Parkinson's disease: nutritional correlates of
body compositionArthur Oscar Schelp, Jéssica Emy Komuro, José Eduardo
Corrente and Silvia Justina Papini
36. The role of the gastrointestinal system and gut microbiota in
Parkinson's diseaseJade Kenna and Ryan S. Anderton
37. Swallowing impairment in Parkinson's diseaseMaira Rozenfeld Olchik,
Marina Padovani and Annelise Ayres
38. The Mini Nutritional Assessment (MNA) and applications to Parkinson's
diseaseSvetlana Tomic
39. The efficacy of Bacopa monnieri extract in modulating Parkinson's
diseaseDr. Ravikumar Hosamani
Part V: Models, modelling and resources
40. 6-hydroxydopamine-induced model of Parkinson's diseaseKatarzyna
Kaczynska and Kryspin Andrzejewski
41. Knockdown transgenic Drosophila and Parkinson's diseaseMarlene
Jimenez-Del-Rio and Carlos Velez-Pardo
42. Neuroprotection in animal models of Parkinson's disease: exploring
exercise, sound, and lightJohn Mitrofanis
43. Modeling with the A53T a-synuclein model of Parkinson's diseaseThomas
Musacchio, James B. Koprich and Chi Wang Ip
44. Linking the leucine-rich repeat kinase 2 gene, animal models, and
Parkinson's diseaseYulan Xiong and Jianzhong Yu
45. Neuroscience of Parkinson's disease: recommended reading and
resourcesRajkumar Rajendram, Vinood B. Patel and Victor R. Preedy
2. Alpha-synuclein gene and Parkinson's diseaseAthina-Maria Simitsi,
Chistos Koros and Leonidas Stefanis
3. The DJ-1 gene and protein: links with Parkinson's diseaseVanessa J.
Musco, Sarah J. Annesley and Paul R. Fisher
4. Regulation of tyrosine hydroxylase: relevance to Parkinson's
diseaseGelareh Alam and Jason R. Richardson
5. Linking glucocerebrosidase gene (GBA) variants and Parkinson's
diseasectoria Berge-Seidl and Mathias Toft
6. Astrocytes and microglia in Parkinson's disease and animal
modelsKatarzyna Kuter
7. The role of autophagy in Parkinson's disease etiopathogenesisEmanuel
Candeias, Jãao Duarte Magalhães, Daniel Santos, Helena Costa, Diana F.
Silva, Ana Raquel Esteves and Sandra Morais Cardoso
8. The mitochondrial network in Parkinson's diseaseAndreas Aufschnaiter,
Verena Kohler and Sabrina Büttner
9. Signal transduction in Parkinson's disease: modulation of
neurotransmission, symptomatology, and therapyMattia Volta
10. Oxidative stress signaling and regulated cell death in Parkinson's
diseaseCarlos Velez-Pardo and Marlene Jimenez-Del-Rio
11. Subcellular-specific alpha-synuclein in Parkinson's diseaseBenjamin
Rosen, Ketan S. Patil, Guido W. Alves and Simon G. Møller
12. Melanocortin 1 receptor: Parkinson's disease, melanoma risk, and
neuroprotectionGemma Tell-Marti, Joan Anton Puig-Butillé and Susana Puig
13. Energy regulation and Parkinson's diseaseLiting Hang and Kah-Leong Lim
14. Linking rotigotine, Parkinson's disease, and brain-derived neurotrophic
factorKazuhiro Sohya, Kazunori O'Hashi and Hiroshi Kunugi
Part II: Neurology, physiology and imaging
15. The different syndromes in Parkinson's disease: an overviewNikolaos
Giagkou and Maria Stamelou
16. Neuromolecular imaging in Parkinson's diseasePatricia A. Broderick and
Leslie Wenning
17. Interlinking brain mapping and Parkinson's disease: MRI analysis,
nigrosome 1 and nigrosome 4Eung Yeop Kim, Young Hee Sung and Jongho Lee
18. Interconnecting Parkinson's disease: the use of computed tomography and
microelectrode recording in DBS surgeryRyan B. Kochanski and Sepehr Sani
19. Linking diffusion tensor imaging, microstructures and Parkinson's
diseaseYu Zhang, Norbert Schuff, I-Wei Wu and Duygu Tosun
20. Detecting parkinsonian degeneration in lateroventral tier of substantia
nigra pars compacta with MRIJason Langley, Daniel E. Huddleston and
Xiaoping P. Hu
21. Vagal motoneurons in Parkinson's diseaseRuth E. Musgrove, Wei-Hua Chiu
and Joshua A. Goldberg
22. Circadian clock disruption and neuroinflammation in Parkinson's
disease: a new perspective Elisabetta Lauretti and Domenico Praticò
23. Motor cortex stimulation in Parkinson's diseaseAngelo Lavano, Giusy
Guzzi, Attilio Della Torre and Domenico La Torre
24. Action programming disorders associated with Parkinson's diseaseKenneth
M. Heilman
25. The striatal medium spiny neurons: what they are and how they link with
Parkinson's diseaseFu-Ming Zhou
26. Disruptions of frontostriatal language functions in Parkinson's
diseaseAdolfo M. García, Yamile Bocanegra, Agustina Birba, Juan Rafael
Orozco-Arroyave, Lucas Sedeño and Agustín Ibañez
27. Alpha-synuclein and neuroinflammation in Parkinson's diseaseTatiana
Varanita and Luigi Bubacco
28. Tau and its interactions with other proteins in neurodegenerative
diseasesKatelyn H. Mroczek, Sarah J. Annesley and Paul R. Fisher
29. Interaction between brain angiotensin and dopaminergic systems and
Parkinson's diseaseJose Luis Labandeira-Garcia, Pablo Garrido-Gil, Maria A.
Pedrosa, Carmen M. Labandeira and Ana I. Rodriguez-Perez
30. Restoring dopamine levels in Parkinson's disease: neuronal pathways,
agonists and antiinflammatory agentsÁgatha Oliveira-Giacomelli, C.M.
Albino, Hellio Danny Nóbrega de Souza and Henning Ulrich
Part III: Behaviour and psychopathology
31. Motivation and motivational aspects of Parkinson's diseaseAbdeslam
Chagraoui, Emilie Puginier and Philippe De Deurwaerdère
32. Linking anxiety, cognitive and sensory deficits to gait and balance
deficits in Parkinson's diseaseQuincy J. Almeida
33. Motor programs interlinking gait and bradykinesia in Parkinson's
diseaseTateo Warabi, Kiyoharu Inoue and Nobuo Yanagisawa
34. Olfactory disturbances in Parkinson's diseaseLais S. Rodrigues, Juliane
Fagotti, Adriano D.S. Targa, Ana Carolina D. Noseda, Jessica L. Ilkiw,
Flavia W.C. Dorieux and Marcelo M.S. Lima
35. Interlinking dementia in Parkinson's disease: nutritional correlates of
body compositionArthur Oscar Schelp, Jéssica Emy Komuro, José Eduardo
Corrente and Silvia Justina Papini
36. The role of the gastrointestinal system and gut microbiota in
Parkinson's diseaseJade Kenna and Ryan S. Anderton
37. Swallowing impairment in Parkinson's diseaseMaira Rozenfeld Olchik,
Marina Padovani and Annelise Ayres
38. The Mini Nutritional Assessment (MNA) and applications to Parkinson's
diseaseSvetlana Tomic
39. The efficacy of Bacopa monnieri extract in modulating Parkinson's
diseaseDr. Ravikumar Hosamani
Part V: Models, modelling and resources
40. 6-hydroxydopamine-induced model of Parkinson's diseaseKatarzyna
Kaczynska and Kryspin Andrzejewski
41. Knockdown transgenic Drosophila and Parkinson's diseaseMarlene
Jimenez-Del-Rio and Carlos Velez-Pardo
42. Neuroprotection in animal models of Parkinson's disease: exploring
exercise, sound, and lightJohn Mitrofanis
43. Modeling with the A53T a-synuclein model of Parkinson's diseaseThomas
Musacchio, James B. Koprich and Chi Wang Ip
44. Linking the leucine-rich repeat kinase 2 gene, animal models, and
Parkinson's diseaseYulan Xiong and Jianzhong Yu
45. Neuroscience of Parkinson's disease: recommended reading and
resourcesRajkumar Rajendram, Vinood B. Patel and Victor R. Preedy